NexxGen Veterinary Presents

AcquGEN Technology

NexxGen Veterinary is a trailblazer in the field of Molecular Diagnostics, introducing groundbreaking technologies that are set to redefine patient diagnosis and treatment. The company's flagship innovation is the AcquGen Technology, which includes the AcquGen Multiplexing Assays, AcquGen Target Sequencer, AcquGen Genomic Chip, and Serology Chips.

AcquGEN Microarray Logo

AcquGen

Target Sequencing Technology

ACQUGEN Automated Target Sequencing Technology is a revolutionary approach to genetic and serology diagnostics. This technology allows for the rapid and accurate identification of genetic markers associated with a wide range of diseases and conditions. By providing clinicians with precise genetic information, this technology enables more effective prevention, treatment, and monitoring of diseases. A fully automated system that streamlines operations. From Sample to Results!

AcquGen

Automated Target Sequencer Exclusives

The ACQUGEN ATS is the first of it's kind technology that allows laboratories to diagnose both Advanced Genetic Diagnostics, coupled with lower cost Serology Tests. 

This will dramatically reduce costs on staffing, operations, maintenance and improve valuable lab space.

autogenomics machine 2 Lid Down No Shadow 2
Picture2

AcquGen Genomic Chip &

Serology Chip

The AcquGen Genomic Chip and AcquGen Serology Chip are integral components of NexxGen's diagnostic arsenal. These chips are designed to work in tandem with the AcquGen Target Sequencer, providing a comprehensive solution for genetic and serological testing. They offer unparalleled speed, accuracy, and sensitivity, significantly improving lab workflow and diagnostic efficiency.
Image

Schedule A Call

NexxGen Veterinary is revolutionizing personalized medicine and targeting key health areas with its innovative molecular assays. By focusing on these critical areas, NexxGen Genomics is poised to make a significant impact on global health outcomes, improving patient diagnosis and treatment across a broad spectrum of diseases and conditions.

To explore more about our technology in an easy-to-understand format, let’s schedule you a call with one of our key stakeholders to further articulate our scientific methods.

Schedule